Archive

It’s Drug-Price Transparency Season ... But Disclosures May Be on the Wane

It’s Drug-Price Transparency Season ... But Disclosures May Be on the Wane

And a J&J lawsuit over biosimilars is the first shot in the war against PBM-backed pseudo-pharma companies

Brian Reid
Brian Reid
GLP-1s Are Out of Shortage, Putting Compounders on Very Thin Ice All of Sudden

GLP-1s Are Out of Shortage, Putting Compounders on Very Thin Ice All of Sudden

Plus a look at how the price of SpringWorks’ Gomelki was disclosed

Brian Reid
Brian Reid
A Blizzard of Quick Hits to Get You to the Weekend

A Blizzard of Quick Hits to Get You to the Weekend

Spring might be around the corner, but the news on 340B, IRA, gene therapies, insulin, and more continues to accumulate

Brian Reid
Brian Reid
Here’s A Thought Experiment: What Would Happen If 340B Profits Were Directed to Retiring Medical Debt?

Here’s A Thought Experiment: What Would Happen If 340B Profits Were Directed to Retiring Medical Debt?

And the attacks on Antonio Ciaccia continue, but his work remains unimpeached

Brian Reid
Brian Reid
Stelara Biosimilars Begin to Launch, Showcasing (Again) the Weirdness of a System that Doesn’t Reward Low Prices

Stelara Biosimilars Begin to Launch, Showcasing (Again) the Weirdness of a System that Doesn’t Reward Low Prices

And shadowy forces are coming for Antonio Ciaccia ... suggesting that Antonio is on to something

Brian Reid
Brian Reid
New JAMA Research Shows How Much -- and How Rapidly -- Part D Plans Have Shifted Drug Costs to Consumers

New JAMA Research Shows How Much -- and How Rapidly -- Part D Plans Have Shifted Drug Costs to Consumers

And we have results from the how-long-will-Kennedy-last poll!

Brian Reid
Brian Reid
Well, It Really Happened. Kennedy Is the Secretary of HHS

Well, It Really Happened. Kennedy Is the Secretary of HHS

And his tenure is starting with a mandate to create a new report that probably won't generate the answers it needs to generate

Brian Reid
Brian Reid
There's an Abbreviation for Everyone Today: PBM, IRA, 340B, RFK, ICER, NPLB

There's an Abbreviation for Everyone Today: PBM, IRA, 340B, RFK, ICER, NPLB

It's one of those drinking-from-a-firehose days

Brian Reid
Brian Reid
Judge Pauses Trump Effort to Massively Role Back Funding for NIH Grantees

Judge Pauses Trump Effort to Massively Role Back Funding for NIH Grantees

Plus your podcast suggestions, Trump comments on GLP-1s, and a comic strip about 340B cats (really)

Brian Reid
Brian Reid
Gearing Up for the Battle -- and the Battles to Come -- Over Innovation

Gearing Up for the Battle -- and the Battles to Come -- Over Innovation

Plus thoughts on health-related touchdowns (and fumbles) from the Super Bowl ad barrage

Brian Reid
Brian Reid
340B Is Driving Up Employer Costs by Billions, State-by-State IQVIA Assessment Shows

340B Is Driving Up Employer Costs by Billions, State-by-State IQVIA Assessment Shows

And it’s a trifecta: there’s 340B, PBM, and IRA news for you all. Also: Go Philly!

Brian Reid
Brian Reid
Part D Benefit Redesign Will Cost Drug Companies Billions This Year ... And That's OK

Part D Benefit Redesign Will Cost Drug Companies Billions This Year ... And That's OK

Plus Kennedy's nomination is suddenly on solid ground after he made "serious commitments," for what that's worth

Brian Reid
Brian Reid
FirstBack
12345678
Next Last